What are the best penny stocks to gain huge returns in 2025
Sign Up to our stock-market-based Q&A Platform to ask questions, answer people’s questions, and connect with other people.
Login to IndianStox.com (Q&A Engine) to ask questions, answer people's questions & connect with other people.
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Top 5 Multibagger Penny Stocks for 2025
If you would like to invest in penny stocks, do some fundamental analysis before investing. I have picked out a few multibagger penny stocks that may give good returns in 2025.
Buy and hold the shares at a low share price (ranging from INR 1.00 to INR 10.00) and sell them when it gives good returns.
Remember!
Not all penny stocks become multibagger stocks over time, only a few stocks operating get marked as fortune providers in the stock markets for you. Don’t you want to be…If so,
Below, you can get a detailed description of the company details & the investment strategy.
You can even make a note of the 5 multibagger stocks that can pay out rich dividends on your investments.
In nutshell, you can count on these five stocks for 2025 in India and they are:
Investment Strategy of the Multibagger Penny Stocks:
Make an investment in small amounts you can still obtain good volumes since the share price is very low from a few paise to few rupees.
Make your investment in at least 3 and above stocks. Plan to buy your chosen stocks in high volumes.
1. Kothari Sugars & Chemicals Ltd
Company Profile:
Kothari Group holds its subsidiary unit, Kothari Sugars & Chemicals Limited operates sugar mills at Kattur Village in Trichy district, Tamil Nadu and Sathamangalam village.
Business Verticals:
The company mainly operates in three sectors which are sugar, alcohol and power.
Financial Position:
Surpassing 3 yr Revenue CAGR:
The company has obtained an impressive annual revenue growth of 43.74% outperformed its 3 year CAGR of 19.86.
Employee & Interest Expenses:
Company has utilised 1% of the operating costs to make the payments of the interest expenses.
To make the employee cost by the year end March 31, 2023 the company has spent 5.46%.
Key Metrics:
PE Ratio : 11.58 | PB Ratio : 1.86 | Face Value : 10.00 | EPS – TTM : 4.46 | 52W H/L : 63.80/32.40 | Market Capital : 428.12 crore |
2. Indraprastha Medical Corporation Ltd
Company Profile:
A joint venture between Apollo Hospitals & Delhi government,
Indraprastha Medical Corporation Ltd was established in 1988, is currently a super speciality tertiary care hospital in New Delhi and constitutes 52 speciality departments.
Business Details:
Besides 52 special departments in Indraprastha Medical Corporation Ltd, the corporation has 754 beds and in the Noida sector, the branch has 46 beds and is categorised under Mama & Child care hospital.
Financial Position:
Surpassing 3 Yr Revenue CAGR
The company did obtain an annual revenue growth of 24.39% and it has outperformed the 3 yr- CAGR of 9.96%.
Employee & Interest Expenses
The company has paid out the interest expenses to the order of less than 1% of the operating revenue.
Further, it has spent 22.45 % against the employee cost in the year ending March 31, 2023.
Key Metrics:
PE Ratio : 16.16 | PB Ratio : 3.90 | Face Value : 10.00 | Market Capital : 1557.52 |
3. Saksoft Ltd
Established in 1999, Saksoft Ltd operates for businesses in the USA, and the UK, engages their clients by providing business intelligence, and information management solutions. The owner Mr. Autar Krishna, and Mr. Aditya Krishna does provide digital services to mid-tier companies.
Business Activities:
The company provides digital transformation solutions, such as application development testing, and quality control, cloud based solutions, and internet of things.
Financial Position:
Surpassing the 3-yr CAGR:
The company’s annual growth rate over the past three years is 22.75% and the current year 2022-2023 growth rate is 37.34% has outperformed for 3 years.
Employee & Interest Expense:
The company has spent to repay the interest expenses less than 1% of its operating costs.
It has spent 44.76% towards the employee cost in the year ending 2023.
Key Metrics:
PE Ratio : 44.09 |PB Ratio : 8.79 |Face Value : 1.00 |EPS TTM : 8.43 |Market Capital : 3,938.31 cr |
4. InfoBeans Technologies Ltd
InfoBeans Technologies provides digital solutions in software development services, business application development for web & mobile apps, and develops the capability maturity model integration for clients. In addition it develops product engineering software.
Business Activities:
The company promotes for their clients, the activities in IT-BPM industry, and Product engineering.
In the IT-BPM segment, it promotes services related to cloud, UX, Application modernization, packaged implementation, and enterprise mobility.
In the product engineering segment, it conducts robotic process automation, RPA, service now, content management, automation, and data transformation.
Financial Position:
Key Metrics:
PE ratio : 46.02 | PB ratio : 4.19 | Face Value : 10.00 | EPS : 8.96 |52W H/L : 580.10/399.80 |Market Capitalisation : 1001.34 cr |
Employee & Interest Expenses:
The company has spent 2.03 % of its operating revenues to make the payment of interest expenses and in the year ending March 31 2023, the company has spent 69.83% against the employee cost.
5. RPG Life Sciences Ltd:
Harsh Goenka heads the RPG Life Sciences Ltd, a part of the RPG group, the company operates in two specific segments, marketing of Finished Doges, and Active Pharmaceutical Ingredients, API, for the domestic/international markets.
The RPG group is diversified into several business areas like information technology, energy and plantations, tyres, and infrastructure.
Financial Position:
Key Metrics:
PE ratio (31.83) |PB ratio (6.76) |Face Value (INR 8.00) |Market Cap ( 2463.90crore)|
CAGR Comparison:
The company annual revenue growth (16.8 %) has outperformed its 3 year growth of CAGR (11.1%).
Employee and Interest Expenses:
Employee & Interest Expenses:
To cover up the interest expenses, the company has spent less than 1% of its operating cost.
Further, the company has spent 22.83% against employee cost in the year ending 31 March 2023.